World Health Organization (WHO) publishes article on benchmarks for equitable hip-fracture care and osteoporosis treatment in older people
December 9, 2025
In Canada, one in three hip fracture patients will re-fracture within one year and 22% of women and 33% of men who suffer a hip fracture will die within one year.
Worldwide, hip fractures cause major morbidity, mortality and long-term disability among older persons. The World Health Organization (WHO) has defined two key indicators within the framework of the UN Decade of Healthy Ageing to measure health system performance in providing care for older adults with hip fractures: the proportion who receive surgery within 48 hours of fracture; and the proportion who receive pharmacological treatment for osteoporosis post-fracture.
The WHO has published a paper making a link between the activities of the WHO Collaborating Centre and the five-year partnership between ESCEO and WHO to improve the management of osteoporosis around the world.
Health Canada Approves of DENOZA™, a Denosumab Biosimilar
May 5, 2026
Latest News Health Canada Approves of DENOZA™, a Denosumab Biosimilar May 5, 2026 Apotex Inc., a Canadian based global pharmaceutical company announced that Health Canada has approved DENOZA™ (denosumab injection), […]
Latest News Positive Outcome for BMD Testing in Ontario April 30, 2026 At Osteoporosis Canada, we are aware that the April 1, 2026 updates to the Schedule of Benefits included […]
April 24, 2026 Contributors: Dr. Adrian Lau, Dr. Heather McDonald-Blumer, Dr. Laëtitia Michou, Dr. Claudia Gagnon, Dr. Zahra Bardai , Dr. Vithika Sivabalasundaram, Sarah Rydahl, Dr. Shirine Usmani, As of April […]
